Gritstone bio Inc (GRTS) ニュース

Form 8-K - Current report

Form 8-K - Current report

Form 8-K - Current report

Gritstone bio Takes Action to Preserve Value and Strengthen Capital Structure

Voluntarily Files for Chapter 11 Restructuring Strategic Alternatives Process Continues with Interest from Parties Gritstone bio, Inc. (Nasdaq:...

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Gritstone bio Reports Second Quarter 2024 Financial Results and Provides Corporate Updates

-- Preliminary randomized Phase 2 data suggest GRANITE (personalized neoantigen vaccine) could drive meaningful...

Lost Money on Gritstone bio, Inc.(GRTS)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm

Lost Money on Gritstone bio, Inc.(GRTS)? Join Class Action Suit Seeking Recovery - Contact The Gross Law...

Gritstone bio, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before August 6, 2024 to Discuss Your Rights - GRTS

Gritstone bio, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before August 6, 2024 to Discuss Your Rights...

Gritstone Bio Inc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - GRTS

Gritstone Bio Inc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights...

Gritstone bio to Host Virtual KOL Event to Discuss Unmet Need and Potential Role of Its Personalized Cancer Vaccine, GRANITE, in Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)

-- Event will feature Dr. Randolph Hecht (Professor, UCLA GI Oncology Program) and Howard Brown (CRC Survivor...

The Gross Law Firm Notifies Shareholders of Gritstone bio, Inc.(GRTS) of a Class Action Lawsuit and an Upcoming Deadline

The Gross Law Firm Notifies Shareholders of Gritstone bio, Inc.(GRTS) of a Class Action Lawsuit and an...